Hedge Fund - Casdin Capital
Sarepta Therapeutics Inc. (SRPT)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $57,487,971 | 4.7% | 900,783 | $105.27 |
| 2 | 2024 - Q4 (2024-12-31) | $130,526,865 | 8.68% | 1,073,500 | $122.55 |
| 3 | 2024 - Q3 (2024-09-30) | $134,069,415 | 8.93% | 1,073,500 | $138.24 |
| 4 | 2024 - Q2 (2024-06-30) | $169,613,000 | 12.95% | 1,073,500 | $128.46 |
| 5 | 2024 - Q1 (2024-03-31) | $138,392,740 | 10.28% | 1,069,000 | $122.50 |
| 6 | 2023 - Q4 (2023-12-31) | $97,056,795 | 9.52% | 1,006,500 | $95.93 |
| 7 | 2023 - Q3 (2023-09-30) | $122,472,203 | 13.55% | 1,010,330 | $113.03 |
| 8 | 2023 - Q2 (2023-06-30) | $116,237,800 | 10.15% | 1,015,000 | $128.81 |
| 9 | 2023 - Q1 (2023-03-31) | $159,882,800 | 13.16% | 1,160,000 | $129.72 |
| 10 | 2022 - Q4 (2022-12-31) | $170,397,700 | 13.2% | 1,315,000 | $115.88 |
| 11 | 2022 - Q3 (2022-09-30) | $135,412,000 | 8.89% | 1,225,000 | $100.79 |
| 12 | 2022 - Q2 (2022-06-30) | $48,724,000 | 4.11% | 650,000 | $73.57 |
| 13 | 2022 - Q1 (2022-03-31) | $62,496,000 | 2.8% | 800,000 | $76.58 |
| 14 | 2021 - Q4 (2021-12-31) | $121,568,000 | 3.42% | 1,350,000 | $85.49 |
| 15 | 2021 - Q3 (2021-09-30) | $101,728,000 | 2.53% | 1,100,000 | $77.03 |
| 16 | 2021 - Q2 (2021-06-30) | $68,800,000 | 1.74% | 885,000 | $75.81 |
| 17 | 2021 - Q1 (2021-03-31) | $40,992,000 | 1.22% | 550,000 | $92.28 |
| 18 | 2020 - Q4 (2020-12-31) | $90,360,000 | 2.67% | 530,000 | $148.17 |
| 19 | 2020 - Q3 (2020-09-30) | $74,428,000 | 3.33% | 530,000 | $151.97 |
| 20 | 2020 - Q2 (2020-06-30) | $84,980,000 | 5.02% | 530,000 | $136.08 |
| 21 | 2020 - Q1 (2020-03-31) | $65,539,000 | 6.95% | 670,000 | $114.31 |
| 22 | 2019 - Q4 (2019-12-31) | $86,457,000 | 7.95% | 670,000 | $100.93 |
| 23 | 2019 - Q3 (2019-09-30) | $66,281,600,000 | 6.85% | 880,000 | $118.10 |
| 24 | 2019 - Q2 (2019-06-30) | $50,903,250,000 | 4.76% | 335,000 | $121.54 |
| 25 | 2019 - Q1 (2019-03-31) | $36,353,000 | 3.99% | 305,000 | $128.56 |
| 26 | 2018 - Q4 (2018-12-31) | $16,370,000 | 2.8% | 150,000 | $125.06 |
| 27 | 2018 - Q3 (2018-09-30) | $6,460,000 | 0.78% | 40,000 | $136.70 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:6.0000 on 2012-07-12